Supplementary Materials

Supplementary Material for:

Targeting BCL-2 and ABL/LYN in Philadelphia chromosome–positive acute lymphoblastic leukemia

Jessica T. Leonard, Joelle S. J. Rowley, Christopher A. Eide, Elie Traer, Brandon Hayes-Lattin, Marc Loriaux, Stephen E. Spurgeon, Brian J. Druker, Jeffrey W. Tyner, Bill H. Chang*

*Corresponding author. Email: changb{at}ohsu.edu

Published 31 August 2016, Sci. Transl. Med. 8, 354ra114 (2016)
DOI: 10.1126/scitranslmed.aaf5309

This PDF file includes:

  • Fig. S1. Dose-response curves for SUPB15 cells treated with the combination of cytotoxic chemotherapy and venetoclax.
  • Fig. S2. Dose-response curves for SUPB15 cells treated with the combination of TKI and venetoclax.
  • Fig. S3. Phosphoproteome Profiler Array comparing imatinib versus dasatinib.
  • Table S1. Combination indices of TKIs and cytotoxic chemotherapy with venetoclax.

[Download PDF]